The nature of the discontinuation syndrome associated with antidepressant drugs

J Clin Psychiatry. 2006:67 Suppl 4:3-7.

Abstract

A common phenomenon accompanying treatment with nearly every major class of antidepressant is the emergence of the discontinuation syndrome in some patients. It is seen most frequently after the abrupt cessation of agents with shorter half-lives. The term withdrawal has been used in the past; however, the distinctions between discontinuation symptoms and drug withdrawal are clear. Thus, the use of proper terminology when discussing this phenomenon with patients will help to alleviate concerns and stop the spread of common misperceptions. In addition, awareness of the unique nature of discontinuation effects and a grasp of the typical time frame of their emergence can assist in distinguishing between discontinuation syndrome and relapse. As a result, it is vital that both patients and their relatives, especially caregivers, be provided with adequate education and a realistic and objective appraisal of expected outcomes upon initiation of antidepressant treatment.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antidepressive Agents / adverse effects*
  • Antidepressive Agents / pharmacokinetics
  • Antidepressive Agents / therapeutic use
  • Behavior, Addictive / diagnosis
  • Caregivers / education
  • Depressive Disorder / drug therapy
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Humans
  • Infant, Newborn
  • Maternal-Fetal Exchange
  • Neonatal Abstinence Syndrome / diagnosis
  • Neonatal Abstinence Syndrome / etiology
  • Patient Education as Topic
  • Pregnancy
  • Selective Serotonin Reuptake Inhibitors / administration & dosage
  • Selective Serotonin Reuptake Inhibitors / adverse effects
  • Selective Serotonin Reuptake Inhibitors / pharmacokinetics
  • Substance Withdrawal Syndrome / diagnosis*
  • Substance Withdrawal Syndrome / etiology*
  • Substance Withdrawal Syndrome / psychology
  • Syndrome
  • Terminology as Topic*

Substances

  • Antidepressive Agents
  • Serotonin Uptake Inhibitors